Drawing for XYVENTIX

USPTO serial 99459109

XYVENTIX

Reviewed by CopyMark Law Group

Status 681
Filing date
Status date
Registration date
—
Examiner
KON, ELISSA GARBER
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with XYVENTIX?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Alison M. Caless

Alison M. Caless Cantor Colburn LLP20 Church StreetFloor 22Hartford, CT 06103

Goods and services

ClassDescriptionStatusFirst use
005Analgesics; anesthetics for peri-operative and post-operative use; pharmaceutical preparations for the relief of pain; pharmaceutical preparations and substances for use in anesthesia for surgical and non-surgical use and for the treatment and control of pain; reagents for medical and veterinary use; chemical preparations for use in the pharmaceutical, medical, and veterinary fields, namely, pharmaceutical preparations for emergency treatment of pain, and for the monitoring and treatment of pain and cancer; pharmaceutical preparations for use after cosmetic surgery for pain; surgical and non-surgical anesthetics; injectable suspension-type drug delivery agents consisting of compounds for facilitating the delivery of pharmaceuticals and analgesics; pharmaceutical preparations for the treatment of joint diseases and pain; pharmaceutical preparations, namely, corticosteroids for the treatment of osteoarthritis pain; liposome formulations containing pharmaceutical preparations and substances for use in anesthesia and for the treatment and control of painACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 4, 2026NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Oct 7, 2026CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 1, 2026TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Oct 1, 2026CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 1, 2026ALIEASSIGNED TO LIE—
Sep 28, 2026ERSITEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED—
Jun 11, 2026GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Jun 11, 2026GNSLLETTER OF SUSPENSION E-MAILED—
Jun 11, 2026CNSLSUSPENSION LETTER WRITTEN—
Jun 5, 2026TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jun 5, 2026CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 5, 2026TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 10, 2026GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 10, 2026GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 10, 2026CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 10, 2026DOCKASSIGNED TO EXAMINER—
Oct 23, 2025MAFRAPPLICATION FILING RECEIPT MAILED—
Oct 23, 2025NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 23, 2025NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance